Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL

NCT03602157 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms
Cutaneous Lymphoma
Cutaneous Anaplastic Large Cell Lymphoma
Mycosis Fungoides
Sezary Syndrome
Lymphomatoid Papulosis
Cutaneous T Cell Lymphoma
Gray Zone Lymphoma

Interventions

BIOLOGICAL: ATLCAR.CD30.CCR4 cells
BIOLOGICAL: ALTCAR.CD30 cells
DRUG: Bendamustine
DRUG: Fludarabine

Sponsor

UNC Lineberger Comprehensive Cancer Center

Collaborators

[object Object]
[object Object]